Amazon Great Indian Festival 2020 - Electronics
Mutual Funds Commodities Research Tax Planning IPO Our Team Contact Us    
Google
Web www.equitybulls.com
Amazon Great Indian Festival 2020 - Electronics
Research

| More

Dr. Reddy's Lab - Sep 17, 2020 - Angel Broking

Posted On: 2020-09-17 02:35:27


Mr. Yash Gupta - Equity Research Associate, Angel Broking Ltd

"Dr. Reddy's Laboratories along with its subsidiaries together announces the launch of over-the-counter Olopatadine Hydrochloride Ophthalmic Solution USP, 0.2% and 0.1%, the storebrand equivalents of Pataday® Once Daily Relief and Pataday® Twice Daily Relief, in the U.S. market, as approved by the U.S. Food and Drug Administration (USFDA). Dr. Reddy's Olopatadine Hydrochloride Ophthalmic Solution USP, 0.2% and 0.1% are indicated for the temporary relief of itchy eyes due to pollen, ragweed, grass, animal hair and dander. The Olopatadine Hydrochloride Ophthalmic Solution USP, 0.1% is also indicated for the temporary relief of red eyes. The Pataday® brand had U.S. sales of approximately $31 million since the launch in March 2020 according to IRi*. This is one of the important additions to its OTC product portfolio in the USA for the company. This will be a positive development for the Dr. Reddy's laboratories."

Shares of DR.REDDY'S LABORATORIES LTD. was last trading in BSE at Rs.4631.55 as compared to the previous close of Rs. 4443.2. The total number of shares traded during the day was 98880 in over 10430 trades.

The stock hit an intraday high of Rs. 4651.95 and intraday low of 4411.5. The net turnover during the day was Rs. 451412307.


Source: Equity Bulls

Click here to send ur comments or to feedback@equitybulls.com

Amazon Great Indian Festival 2020 - Mobiles


Disclaimer:The article above is a gist / extract of the original report prepared by the research firm / brokerage firm. This article is not to be considered as an offer to sell or a solicitation to buy any securities. This article is meant for general information only. www.equitybulls.com, its employees or owners or the research firms, its employees or owners won't be responsible for any liability that may arise from information, errors or omissions in these articles. www.equitybulls.com or its employees or owners / the research firms or its employees or clients or owners may from time to time hold positions in securities referred in this article. For detailed research reports, please contact the concerned research firm directly.





Other Headlines:

Maintain ADD on L&T Infotech - Growth progression continues - HDFC Securities

Cipla Ltd - Launch of generic Nintedanib - Angel Broking

Britannia Industries Ltd - Q2 FY21 Result Update - YES Securities

Hindustan Unilever Ltd - Q2 FY21 Result Update - YES Securities

CCL Products Ltd - Q2 FY21 Result Update - YES Securities

Specialty chemicals - Price trend in Aug-20 - ICICI Securities

Hindustan Unilever - Willingness (necessity?) to sacrifice gross margins to drive growth - ICICI Securities

Britannia Industries - In-home consumption tailwind starts to taper-off - ICICI Securities

Balkrishna Industries - Quarter ends on a strong note - ICICI Securities

Refining & marketing - Diesel cracks: Light at the end of the tunnel? - ICICI Securities

Mahindra CIE Automotive - Resilient margin performance - ICICI Securities

Kajaria Ceramics - Q2FY21 Result Update - ICICI Securities

Hindustan Unilever - Q2FY21 Result Update - ICICI Securities

Castrol India - Initiating Coverage - Compelling Valuation & Counting on Dividend Support - Reliance Research

Reliance Research - R Long Short - Mahindra & Mahindra Financial Services : Directional Long

Kajaria Ceramics - Q2FY21 First Cut - ICICI Securities

Quant Pick - Larsen & Toubro - ICICI Securities

Hindustan Unilever - Q2FY21 First Cut - ICICI Securities

Hindustan Zinc - Q2FY21 First Cut - ICICI Securities

Dhanuka Agritech - Buy back - Angel Broking

Equitas SFB IPO - Day 1 Subscription - Angel Broking

Dr. Reddy's lab relaunch of OTC product - Angel Broking

Hindustan Unilever Ltd - Q2FY21 Results - Angel Broking

Hindustan Unilever Ltd - Q2FY21 Results - YES Securities

Maintain BUY on ACC - Strong cost controls cushion earnings - HDFC Securities

Equitas Small Finance Bank (ESFB) - Subscribe - YES Securities

Granules India - Q2FY2021 results - Angel Broking

Sunteck Realty - Acquisition of 50 acres - Angel Broking

Maintain BUY on Oberoi Realty - Sharp recovery - HDFC Securities

L&T bidding for rail corridor - Angel Broking

Maintain REDUCE on L&T Technology Services - Recovery priced in - HDFC Securities

India IT Services - Thematic - Rising 5G Adoption to Industrialize Digital Services & Connectivity - Reliance Securities

L&T Technology Services - Q2FY21 Result - Angel Broking

L&T Technology Services - 'Multiple' headwinds - ICICI Securities

HDFC Life Insurance Company - Recovery well on track post Covid-19 dip - ICICI Securities

ACC - Strong execution - third time in a row - ICICI Securities

Tata Communications - Keeping faith on sales funnel for revenue growth - ICICI Securities

Hatsun Agro Products - Healthy revenues; strong margins - ICICI Securities

Amber Enterprises Ltd - Business Update Call - YES Securities

Key Takeaways from Q2FY21 earnings call of Shoppers Stop - YES Securities

CSB Bank Q2 FY21 - Not Rated - YES Securities

Britannia Industries 2QFY21 results - YES Securities

HDFC Life Insurance - Q2FY21 Results - YES Securities

ACC Ltd - Q3CY20 Results - YES Securities

IPO Review - Equitas Small Finance Bank - ICICI Securities

Rallis India - Q2FY21 First Cut - ICICI Securities

ACC Ltd - Q3CY20 First Cut - ICICI Securities

Equitas Small Finance Bank Limited - Strongly developing from a microfinance to small bank... - Geojit

Britannia Industries - Q2FY21 Results - Angel Broking

Rallis India - Q2FY21 Results - Angel Broking







Website Created & Maintained by : Chennai Scripts
West Mambalam, Chennai - 600 033,
Tamil Nadu, India

disclaimer copyright © 2005 - 2019